NSIS-B:CPH
Novozymes A/S
DKKÂ 430.50
arrow_upward
+0.49%(+2.10) 1D
Sep 21, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NSIS-B...
Open
DKKÂ 426.40
High
DKKÂ 436.20
Low
DKKÂ 425.90
Mkt. cap
177.74B
Avg. vol.
595.85K
Volume
351.31K
52-wk high
DKKÂ 465.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
Open
DKKÂ 426.40
High
DKKÂ 436.20
Low
DKKÂ 425.90
Mkt. cap
177.74B
Avg. vol.
595.85K
Volume
351.31K
52-wk high
DKKÂ 465.00
52-wk low
DKKÂ 336.80
Shares outstanding
414.56M
No. of employees
11K
News stories
From web sources and news partners
www.marketscreener.com
·
58 minutes ago
Transactions under Novonesis’ share buyback program
AD HOC NEWS
·
2 days ago
Novonesis stock holds steady as share buyback program continues
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S